UofL RBL Operations, Workforce Development and Pandemic Preparedness Research

伦敦大学 RBL 运营、劳动力发展和流行病防范研究

基本信息

  • 批准号:
    10793918
  • 负责人:
  • 金额:
    $ 293.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-18 至 2028-07-31
  • 项目状态:
    未结题

项目摘要

SUMMARY (OVERALL): The University of Louisville Regional Biocontainment Laboratory (RBL) is operated by the University Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM). The RBL is a regional resource that facilitates translational research to develop diagnostics, prognostics, therapeutics and vaccines to mitigate biodefense and emerging infectious disease threats. Our Center operates the only BSL-3 and ABSL-3 facilities currently operating in the Commonwealth of Kentucky. The CPM mandate is to prepare for and respond to public health emergencies, such as the COVID-19 pandemic. The broad, long-range objectives and goals of the University of Louisville (UofL) CPM RBL are: 1. To offer state-of-the-art research services to the regional and national biomedical research community to learn from past pandemics and biological warfare experiences and effectively predict and mitigate future emerging infectious disease threats. 2. To manage, maintain and operate the UofL RBL to serve the national and regional need for biocontainment facilities suitable for research on Risk Group 3 pathogens and other biothreats. 3. To follow a philosophy of continuous improvement in BSL-3 and ABSL-3 work practices and to ensure that all personnel who need to access BSL-3 and ABSL-3 containment laboratories are appropriately trained and prepared to serve the national and regional need for biocontainment research professionals. To achieve these aims we propose to establish three collaborative Cores. The Facilities Management Maintenance and Operations Core (FMMO Core) is responsible for ensuring that the facility is always available to meet the research and emergency preparedness mission of the RBL. The BSL-3 Practices and Workforce Development Core (BSL-3PWD Core) formalizes our mentor-mentee training plan to ensure our laboratory is staffed with BSL-3 research professionals who are proficient at biocontainment research professionals. This core responds to the reality that response to rapidly emerging public health emergencies like COVID-19 is limited by the number of available BSL-3 trained and experienced research professionals. Our Pandemic Preparedness and Response Integrated Research Core (PaPR Core) responds to the substantially increased requests for our BSL-3 research services by organizing an integrated full-service BSL-3 research support function to support investigator needs. These cores will work in unison to achieve the CPM mission: to prepare for and respond to public health emergencies like the COVID-19 pandemic.
SUMMARY (OVERALL): The University of Louisville Regional Biocontainment Laboratory (RBL) is operated by the University Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM). The RBL is a regional resource that facilitates translational research to develop diagnostics, prognostics, therapeutics and vaccines to mitigate biodefense and emerging infectious disease threats. Our Center operates the only BSL-3 and ABSL-3 facilities currently operating in the Commonwealth of Kentucky. The CPM mandate is to prepare for and respond to public health emergencies, such as the COVID-19 pandemic. The broad, long-range objectives and goals of the University of Louisville (UofL) CPM RBL are: 1. To offer state-of-the-art research services to the regional and national biomedical research community to learn from past pandemics and biological warfare experiences and effectively predict and mitigate future emerging infectious disease threats. 2. To manage, maintain and operate the UofL RBL to serve the national and regional need for biocontainment facilities suitable for research on Risk Group 3 pathogens and other biothreats. 3. To follow a philosophy of continuous improvement in BSL-3 and ABSL-3 work practices and to ensure that all personnel who need to access BSL-3 and ABSL-3 containment laboratories are appropriately trained and prepared to serve the national and regional need for biocontainment research professionals. To achieve these aims we propose to establish three collaborative Cores. The Facilities Management Maintenance and Operations Core (FMMO Core) is responsible for ensuring that the facility is always available to meet the research and emergency preparedness mission of the RBL. The BSL-3 Practices and Workforce Development Core (BSL-3PWD Core) formalizes our mentor-mentee training plan to ensure our laboratory is staffed with BSL-3 research professionals who are proficient at biocontainment research professionals. This core responds to the reality that response to rapidly emerging public health emergencies like COVID-19 is limited by the number of available BSL-3 trained and experienced research professionals. Our Pandemic Preparedness and Response Integrated Research Core (PaPR Core) responds to the substantially increased requests for our BSL-3 research services by organizing an integrated full-service BSL-3 research support function to support investigator needs. These cores will work in unison to achieve the CPM mission: to prepare for and respond to public health emergencies like the COVID-19 pandemic.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KENNETH E PALMER其他文献

KENNETH E PALMER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KENNETH E PALMER', 18)}}的其他基金

UofL RBL Pandemic Preparedness and Response Integrated Research Core
UofL RBL 流行病防范和应对综合研究核心
  • 批准号:
    10793921
  • 财政年份:
    2023
  • 资助金额:
    $ 293.57万
  • 项目类别:
Upgrading infectious disease research facilities at University of Louisville RBL
升级路易斯维尔大学 RBL 传染病研究设施
  • 批准号:
    10631406
  • 财政年份:
    2022
  • 资助金额:
    $ 293.57万
  • 项目类别:
Upgrading infectious disease research facilities at University of Louisville RBL
升级路易斯维尔大学 RBL 传染病研究设施
  • 批准号:
    10394525
  • 财政年份:
    2021
  • 资助金额:
    $ 293.57万
  • 项目类别:
Project 2: PREVENT Preclinical safety and efficacy studies
项目2:预防临床前安全性和有效性研究
  • 批准号:
    9276592
  • 财政年份:
    2016
  • 资助金额:
    $ 293.57万
  • 项目类别:
Project 2: PREVENT Preclinical safety and efficacy studies
项目2:预防临床前安全性和有效性研究
  • 批准号:
    8769379
  • 财政年份:
    2014
  • 资助金额:
    $ 293.57万
  • 项目类别:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
基于 Griffithsin 的直肠杀菌剂用于预防病毒进入(预防)
  • 批准号:
    8769373
  • 财政年份:
    2014
  • 资助金额:
    $ 293.57万
  • 项目类别:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
基于 Griffithsin 的直肠杀菌剂用于预防病毒进入(预防)
  • 批准号:
    9095157
  • 财政年份:
    2014
  • 资助金额:
    $ 293.57万
  • 项目类别:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
基于 Griffithsin 的直肠杀菌剂用于预防病毒进入(预防)
  • 批准号:
    8875600
  • 财政年份:
    2014
  • 资助金额:
    $ 293.57万
  • 项目类别:
Antiviral lectins as microbicides
作为杀微生物剂的抗病毒凝集素
  • 批准号:
    7795249
  • 财政年份:
    2008
  • 资助金额:
    $ 293.57万
  • 项目类别:
Antiviral lectins as microbicides
作为杀微生物剂的抗病毒凝集素
  • 批准号:
    8056628
  • 财政年份:
    2008
  • 资助金额:
    $ 293.57万
  • 项目类别:

相似海外基金

SBIR Phase II: A Label-Free Surface-enhanced Raman Spectroscopy-Capture Assay in Microchips for Biological Warfare Agents
SBIR 第二阶段:用于生物战制剂的微芯片中的无标记表面增强拉曼光谱捕获分析
  • 批准号:
    0956170
  • 财政年份:
    2010
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
SBIR Phase I: A Label-Free SERS-Capture Assay in Microchips for Biological Warfare Agents
SBIR 第一阶段:用于生物战剂的微芯片中的无标记 SERS 捕获分析
  • 批准号:
    0810335
  • 财政年份:
    2008
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
SBIR Phase I: Biological Warfare Agent Detection Utilizing Magnetic Nanoparticles for Agent Delivery and an Adaptive Holographic Interferometric System
SBIR 第一阶段:利用磁性纳米粒子进行药剂输送和自适应全息干涉系统进行生物战药剂检测
  • 批准号:
    0539798
  • 财政年份:
    2006
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
STRUCTURE OF VEE VIRUS NSP2 PROTEASE: BIOLOGICAL WARFARE
VEE 病毒 NSP2 蛋白酶的结构:生物战
  • 批准号:
    6978230
  • 财政年份:
    2004
  • 资助金额:
    $ 293.57万
  • 项目类别:
ACT/SGER: Rapid Identification of Biological Warfare Simulants by FTIR
ACT/SGER:通过 FTIR 快速识别生物战模拟物
  • 批准号:
    0346431
  • 财政年份:
    2003
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
Dissertation Research: Reimagining Anthrax: Constructing the Threat and Science of Biological Warfare at Fort Detrick, 1943-1969
论文研究:重新想象炭疽:构建德特里克堡生物战的威胁和科学,1943-1969
  • 批准号:
    0218007
  • 财政年份:
    2002
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
SGER: Activated Hydrogen Peroxide Detoxification of Chemical-Biological Warfare Agents
SGER:生化战剂的活化过氧化氢解毒
  • 批准号:
    0211065
  • 财政年份:
    2002
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
SGER: Inactivation of Biological Warfare Agents by Physical Disinfectants
SGER:物理消毒剂灭活生物战剂
  • 批准号:
    0210350
  • 财政年份:
    2002
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
AFM Sensors to Detect Biological Warfare Agents
用于检测生物战剂的 AFM 传感器
  • 批准号:
    6555461
  • 财政年份:
    2002
  • 资助金额:
    $ 293.57万
  • 项目类别:
Dissertation Research: From Prevention to Infection: Aerobiology, the Industrialization of Disease, & Biological Warfare in the United States, 1920-1960
论文研究:从预防到感染:空气生物学、疾病工业化、
  • 批准号:
    9906621
  • 财政年份:
    1999
  • 资助金额:
    $ 293.57万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了